Skip to main content
Canadian Family Physician logoLink to Canadian Family Physician
. 1987 Nov;33:2529–2533.

Introducing a New Drug into Your Practice

Wilfred H Palmer, Debra L Ross
PMCID: PMC2218682  PMID: 21263993

Abstract

Many consultations in family practice end with a prescription for medication. The average market life of a new drug is only five years. Keeping up to date on therapeutic advances is an essential CME activity. Family physicians usually hear about new drugs from the pharmaceutical representatives. Before one changes well-established habits of practice it is necessary to evaluate non-commercial sources of data. A good understanding of the implications of clinical trials is required. The availability and accuracy of other sources of information are discussed.

Keywords: physicians' practice pattern, prescription drugs, drug utilization

Full text

PDF
2529

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brook R. H., Ware J. E., Jr, Rogers W. H., Keeler E. B., Davies A. R., Donald C. A., Goldberg G. A., Lohr K. N., Masthay P. C., Newhouse J. P. Does free care improve adults' health? Results from a randomized controlled trial. N Engl J Med. 1983 Dec 8;309(23):1426–1434. doi: 10.1056/NEJM198312083092305. [DOI] [PubMed] [Google Scholar]
  2. Croog S. H., Levine S., Testa M. A., Brown B., Bulpitt C. J., Jenkins C. D., Klerman G. L., Williams G. H. The effects of antihypertensive therapy on the quality of life. N Engl J Med. 1986 Jun 26;314(26):1657–1664. doi: 10.1056/NEJM198606263142602. [DOI] [PubMed] [Google Scholar]
  3. Hemminki E. Review of literature on the factors affecting drug prescribing. Soc Sci Med. 1975 Feb;9(2):111–116. doi: 10.1016/0037-7856(75)90103-1. [DOI] [PubMed] [Google Scholar]
  4. Miller S. T., Perry C. New lessons favoring physicians' support of clinical trials. Am J Med. 1984 Sep;77(3):533–536. doi: 10.1016/0002-9343(84)90115-3. [DOI] [PubMed] [Google Scholar]
  5. Peay M. Y., Peay E. R. Differences among practitioners in patterns of preference for information sources in the adoption of new drugs. Soc Sci Med. 1984;18(12):1019–1025. doi: 10.1016/0277-9536(84)90160-6. [DOI] [PubMed] [Google Scholar]
  6. Williamson P. M. How general practitioners assess risks in using new drugs. J R Coll Gen Pract. 1975 May;25(154):383–386. [PMC free article] [PubMed] [Google Scholar]
  7. Yoonessi M., Mariniello D. A., Wieckowska W. S., Angtuaco M. G., Diesfeld P. DES story: review and report. N Y State J Med. 1981 Feb;81(2):195–198. [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES